We and others have shown previously the involvement of CD25 as a biomarker detected in primary BP-CML (14, 20) as well as its expression in in vitro BP-CML models (21). This evidence concerns the gene IL2RA and chronic myelogenous leukemia, BCR-ABL1 positive.